Even though ADH-503 didn't goal T cells instantly, our data propose that it may increase anti-tumor T cell responses. We found that ADH-503 bolstered both equally CD8+ and CD4+ effector T cell responses by increasing their figures, activation, and proliferative position. Interestingly, we noticed enhanced proximity of CD8+ T cells to PDAC cells fol